Product NDC: | 62856-831 |
Proprietary Name: | Aricept |
Non Proprietary Name: | donepezil hydrochloride |
Active Ingredient(s): | 5 mg/1 & nbsp; donepezil hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, ORALLY DISINTEGRATING |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 62856-831 |
Labeler Name: | Eisai Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021720 |
Marketing Category: | NDA |
Start Marketing Date: | 20041018 |
Package NDC: | 62856-831-30 |
Package Description: | 3 BLISTER PACK in 1 CARTON (62856-831-30) > 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK |
NDC Code | 62856-831-30 |
Proprietary Name | Aricept |
Package Description | 3 BLISTER PACK in 1 CARTON (62856-831-30) > 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK |
Product NDC | 62856-831 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | donepezil hydrochloride |
Dosage Form Name | TABLET, ORALLY DISINTEGRATING |
Route Name | ORAL |
Start Marketing Date | 20041018 |
Marketing Category Name | NDA |
Labeler Name | Eisai Inc. |
Substance Name | DONEPEZIL HYDROCHLORIDE |
Strength Number | 5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] |